Nirit has more than 20 years of experience in the cell therapy space, focusing on bioprocess development and quality control. Nirit is an expert in developing cell-based products, including mesenchymal and hematopoietic cells, from research to advanced clinical stages. Before joining NurExone, Nirit led the process development departments at Pluristem and at Emendo Biotherapeutics. In addition, Nirit led the QC department at Pluristem for 4 years, during its phase three multinational clinical studies. Nirit holds an MSc. in Biotechnology from the Hebrew University.
Menu
